Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 6/20 | 0.52 |
| ▸ | AKT2 | P31751 | 4/20 | 0.52 |
| ▸ | AKT3 | Q9Y243 | 4/20 | 0.52 |
| ▸ | PIK3R1 | P27986 | 3/20 | 0.52 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.52 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.46 |
| ▸ | GAB1 | Q13480 | 1/20 | 0.46 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.41 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.41 |
| ▸ | SELL | P14151 | 1/20 | 0.41 |
| ▸ | SELP | P16109 | 1/20 | 0.41 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13058766 | 1.00 | AKT1 (0.52) | AKT1AKT2AKT3PIK3R1PIK3CA | |
| SCHEMBL13058765 | 1.00 | AKT1 (0.52) | AKT1AKT2AKT3PIK3R1PIK3CA | |
| SCHEMBL13058759 | 0.98 | AKT1 (0.52) | AKT1AKT2AKT3PIK3R1PIK3CA | |
| SCHEMBL13058762 | 0.98 | AKT1 (0.52) | AKT1AKT2AKT3PIK3R1PIK3CA | |
| SCHEMBL13058680 | 0.92 | AKT1 (0.58) | AKT1AKT2AKT3PIK3R1PIK3CA | |
| SCHEMBL13058760 | 0.90 | AKT1 (0.49) | AKT1AKT2AKT3PIK3R1PIK3CA | |
| SCHEMBL13058699 | 0.89 | AKT1 (0.56) | AKT1AKT2AKT3PIK3R1PIK3CA | |
| SCHEMBL13058693 | 0.89 | AKT1 (0.56) | AKT1AKT2AKT3PIK3R1PIK3CA | |
| SCHEMBL13058689 | 0.89 | AKT1 (0.56) | AKT1AKT2AKT3PIK3R1PIK3CA | |
| SCHEMBL13058701 | 0.89 | AKT1 (0.54) | AKT1AKT2AKT3PIK3R1PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100297156-A1 | ANALOGUES OF PHOSPHATIDYLINOSITOL MANNOSIDES | INDUSTRIAL RESEARCH LIMITED (NZ) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100297156-A1 | ANALOGUES OF PHOSPHATIDYLINOSITOL MANNOSIDES | PIK3CA, PIK3CB, PIK3CG | AKT1 260/4885AKT2 216/4885AKT3 240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.